Each week, I track the most consequential startup funding rounds, acquisitions, and market movements across Europe to help financial professionals cut through the noise and focus on what matters for deal flow, sector allocation, and capital markets positioning. This week delivered an unusually dense set of signals — spanning deep tech, defence, AgriTech, AI infrastructure, and healthtech — that collectively paint a picture of a European venture ecosystem growing in both ambition and complexity. Here are the ten stories that deserve your attention.
The largest single raise of the week came from Distalmotion, the German medtech startup that secured €70 million in growth funding. In a market where healthtech valuations have been under pressure, this round signals continued institutional appetite for hardware-led medical innovation with clear regulatory pathways and surgical adoption potential.
Not far behind, Lovey announced a €298 million senior secured credit facility from Pollen Street Capital to scale its SME lending operations in the UK. For credit investors and alternative lenders, this deal underscores the ongoing structural shift away from traditional bank financing toward fintech balance-sheet lenders — a trend with direct implications for credit market dynamics and bank revenue pools.
In what may be the week’s most strategically significant transaction, Argotec, the Italian satellite manufacturer, closed a €50 million Series B led by Milan-based Nuo Space, with capital earmarked for scaling production and expanding into the United States. European space-tech has been attracting growing cross-Atlantic interest, and Argotec’s US push is a concrete indicator that the sector is maturing toward transatlantic revenue diversification — a risk-positive signal for investors already exposed to the category.
On the defence-tech front, PDKINEMATICS, a Lithuanian drone startup, raised €2 million to commercialise its jam-resistant precision-guidance module for small UAVs, targeting Ukrainian and European defence clients. While the round is modest in size, it reflects the continued mobilisation of early-stage capital into dual-use technologies — a sector where European sovereign procurement is providing an unusually durable demand floor.
Machenta, a London-based robotics startup spun out of Imperial College, raised a record $40 million seed round co-led by Creandum and Union Square Ventures. The sheer size of this seed — exceptional by any European benchmark — signals that frontier AI-robotics is attracting pre-revenue capital at valuations that would have been unthinkable three years ago, compressing the timeline between research and institutional funding rounds.
European venture fund formation also featured prominently this week, with Entourage closing its second fund at €100 million, surpassing its €75 million target in under two weeks. The fund, focused on pre-seed and seed deals in AI, robotics, and deep tech, reflects robust LP appetite for early-stage European exposure — and the speed of its close is itself a market signal worth noting.
Braid, the Dutch embedded connectivity startup, secured €34.13 million in Series A funding led by Octopus Ventures, with KPN Ventures co-investing. The company is already profitable and cash-flow positive, which in the current environment represents a meaningful differentiator — investors are increasingly rewarding capital efficiency alongside growth, and Braid’s financials make it a benchmark case for the category.
In biotech, Samplix of Denmark announced a €25 million first close, combining €3 million in equity with €22 million in convertible bonds — a structuring approach that will interest debt-equity investors as the biotech sector continues to explore hybrid instruments to manage dilution and runway risk simultaneously.
VitalFluid, the Dutch AgriTech startup, raised €17.2 million co-led by Invest-NL and Alder Tree Investments to commercialise its plasma-activated water technology. The round arrives alongside a stark Invest-NL warning that the Netherlands risks losing its AgriTech leadership — a policy-level signal that regulatory and commercialisation barriers remain significant headwinds for the sector’s risk-adjusted return profile.
Finally, the closure of Tomoni Mental Health, a German nonprofit startup unable to raise a six-figure sum despite its measurable social impact, offers a sobering counterpoint to the week’s headline numbers. It is a reminder that capital concentration in AI and deep tech is leaving genuine funding gaps elsewhere — a dynamic that impact investors and ESG-mandated allocators cannot afford to ignore.
Taken together, this week’s activity suggests European venture capital is in a phase of deliberate concentration: larger rounds, faster fund closes, and growing institutional conviction in deep tech and defence, even as early-stage social impact ventures struggle for oxygen. For asset managers and allocators, the data points toward a European ecosystem that is selectively maturing — and generating the kind of deal complexity that warrants closer, sector-by-sector scrutiny rather than broad index-level exposure.
— Maurizio Savino, Editor in Chief, EU Finance News